Frequency and Structure of Drug Resistance of M. tuberculosis in Pulmonary and Extrapulmonary Tuberculosis

Author:

Yablonskiy P. K.1ORCID,Vishnevskiy B. I.2ORCID,Solovyova N. S.2ORCID,Galkin V. B.2ORCID

Affiliation:

1. St. Petersburg Research Institute of Phthisiopulmonology, Russian Ministry of Health; St. Petersburg University

2. St. Petersburg Research Institute of Phthisiopulmonology, Russian Ministry of Health

Abstract

The objective: to assess changes in the data on drug resistance of M. tuberculosis for 2015-2021 and compare it with data for 2012-2014.Subjects and Methods. Using continuous sampling, the frequency of drug resistance of Mycobacterium tuberculosis (MTB DR) was studied in isolates from 151 pulmonary tuberculosis (PTB) patients and isolates from 805 extrapulmonary tuberculosis (EPTB) patients, who were treated at the clinic of St. Petersburg Research Institute of Phthisiopulmonology in 2015-2021. The results were compared with similar data for 2012-2014 which was published in 2016.Results. In 2015-2021 versus 2012-2014, the overall frequency of MTB DR decreased by 4.2% in pulmonary tuberculosis patients (from 90.1 to 85.9%) and by 2.9% in extrapulmonary tuberculosis patients (from 80.2 to 77.4%). The structure of MTB DR in pulmonary tuberculosis changed insignificantly, the frequency of MDR decreased from 42.5 to 36.5%, and XDR (as per the definitions before 2022) remained the same – 39.5%. In extrapulmonary tuberculosis, the structure of MTB DR deteriorated due to lower frequency of MDR (from 66.3 to 48.3%) and higher frequency of XDR (from 3.2 to 19.0%, p<0.01).

Publisher

LLC "Medical Knowledge and Technologies"

Reference12 articles.

1. Galkin V.B., Sterlikov S.A., Yablonskiy P.K. Tuberculosis burden in the Russian Federation. Part 2. Changes in the prevalence of multiple drug resistant tuberculosis. Meditsinsky Alyans, 2022, vol. 10, no. 4, pp. 6-18. (In Russ.) https://doi.org/10.36422/23076348-2022-10-4-6-18

2. Litvinov V.I., Nosova E.Yu. The problem of drug resistance of M. tuberculosis. Tuberkulez i Sotsialno-Znachimye Zabolevaniya, 2021, no. 2, pp. 70-82. (In Russ.)

3. Naumov A.G., Pavlunin A.V. Mechanisms of development of medicine stability Mycobacterium tuberculosis: is there a chance to win? Pulmonologiya, 2021, vol. 31, no. 1, pp. 100-108. (In Russ.) https://doi.org/10.18093/0869-0189-2021-31-1-100-108

4. Edict no. 109 by RF MoH as of 21.03.2003 On Improvement of TB Control Measures in the Russian Federation. (In Russ.) Available: http://docs.cntd.ru/document/901868614 Accessed April 12, 2023

5. Tuberkulez u vzroslykh. Klinicheskie rekomendatsii KR-16. [Tuberculosis in adults. Guidelines. G-16]. Moscow, 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3